Live Breaking News & Updates on சித்தார்த் ஷா|Page 4
Stay updated with breaking news from சித்தார்த் ஷா. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Why PharmEasy bought Thyrocare SUBSCRIBE Thank you for subscribing to Morning Dispatch We ll soon meet in your inbox. / Morning Dispatch PharmEasy, forked out Rs 4,546 crore for a controlling stake in diagnostics firm Thyrocare last week, becoming the first startup unicorn to acquire a listed legacy company in India. We spoke to Siddharth Shah, co-founder and CEO of API Holdings, on why he decided to buy, and to Arokiaswamy Velumani, promoter of Thyrocare, on why he decided to sell. Also in this letter: How Covid changed CEO salaries Google files first report under IT rules ️ The Rundown by ETtech, our weekly Clubhouse chat show, is back for Season 2! ....
Synopsis API Holdings Siddharth Shah on what’s next for Thyrocare after the PharmEasy deal, API’s existing online drug delivery business, and what he makes of deep-pocketed rivals Reliance and Tata Group. Excerpts from the interview: ETtech Siddharth Shah, co-founder and chief executive of API Holdings which runs PharmEasy. Bengaluru:Siddharth Shah, co-founder and chief executive of API Holdings which runs PharmEasy, has largely been under the radar despite continuous action in the online pharmacy space over the last 12-18 months. But last week Shah hit the headlines, when PharmEasyannounced it is buying diagnostics chain Thyrocare, in the first instance of a unicorn acquiring a listed legacy player in India. ....
Conquering outpatient care: can Thyrocare help PharmEasy cement its top position in digital health? ✖ From left, Siddharth Shah, cofounder & CEO, API Holdings Ltd shakes hands with A Velumani, chairman & managing director, Thyrocare after signing the agreement of acquisition; image courtesy of PharmEasy Synopsis PharmEasy seems to have cemented its position as India’s largest online pharmacy firm with the addition of Thyrocare. It now has a diversified portfolio of offerings and a strong back-end support. With this added muscle, the more than six-year-old startup is now ready to compete with the likes of Tata-backed 1mg, Reliance-Netmeds, and Apollo Hospitals’ 24x7. ....
Online startup PharmEasy to acquire 66% stake in dignostics chain Thyrocare for Rs4,500 cr domain-b.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from domain-b.com Daily Mail and Mail on Sunday newspapers.
Exclusive content, features, opinions and comment - hand-picked by our editors, just for you. Pick 5 of your favourite companies. Get a daily email with all the news updates on them. Track the industry of your choice with a daily newsletter specific to that industry. Stay on top of your investments. Track stock prices in your portfolio. NOTE : The monthly duration product is an auto renewal based product. Once subscribed, subject to your card issuer s permission we will charge your card/ payment instrument each month automatically and renew your subscription. In the Annual duration product we offer both an auto renewal based product and a non auto renewal based product. ....